Shed blood-derived cells from total hip arthroplasty have osteoinductive potential: a pilot study.

Background Cell therapy using autologous cells has been used in the treatment of various medical conditions. The mononuclear cell (MNC) fraction of bone marrow (BM) contains stem/progenitor cells that could contribute to osteogenesis and angiogenesis.